| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.935 | 0 | 0.935 | Angiotensin II receptor antagonist | 0.83 0 DB13919 0.722 0.001 DBMET00005 0.086 0.003 DBMET00006 0.161 0.002 DBMET00007 | ||
| 0.892 | 0 | 0.892 | Angiotensin AT1 receptor antagonist | 0.818 0 DB13919 0.71 0.001 DBMET00005 0.073 0.004 DBMET00006 0.127 0.002 DBMET00007 | ||
| 0.592 | 0.008 | 0.592 | Cardiotonic | 0.48 0.017 DB13919 | ||
| 0.491 | 0.033 | 0.491 | Toll-Like receptor 7 agonist | 0.459 0.041 DB13919 0.287 0.119 DBMET00005 0.212 0.187 DBMET00006 | ||
| 0.487 | 0.034 | 0.487 | Toll-Like receptor agonist | 0.456 0.042 DB13919 0.281 0.123 DBMET00005 0.242 0.156 DBMET00006 | ||
| 0.346 | 0.01 | 0.346 | Insulin sensitizer | 0.321 0.012 DB13919 0.161 0.119 DBMET00005 0.186 0.089 DBMET00006 0.202 0.071 DBMET00007 | ||
| 0.426 | 0.124 | 0.459 | Antiinflammatory | 0.459 0.106 DBMET00007 | DBMET00007 | |
| 0.311 | 0.015 | 0.34 | Hemostatic | 0.154 0.064 DBMET00005 0.34 0.012 DBMET00007 | DBMET00007 | |
| 0.29 | 0.008 | 0.305 | Mediator release inhibitor | 0.305 0.007 DB13919 0.134 0.037 DBMET00007 | DB13919 | |
| 0.314 | 0.065 | 0.314 | Spasmolytic | |||
| 0.361 | 0.115 | 0.547 | Cyclophilin D inhibitor | 0.416 0.082 DB13919 0.475 0.058 DBMET00006 0.547 0.038 DBMET00007 | DBMET00007 | |
| 0.281 | 0.055 | 0.294 | Vasodilator | 0.162 0.14 DB13919 0.227 0.084 DBMET00006 0.294 0.05 DBMET00007 | DBMET00007 | |
| 0.218 | 0.021 | 0.321 | Catenin beta inhibitor | 0.321 0.005 DBMET00005 0.198 0.033 DBMET00007 | DBMET00005 | |
| 0.243 | 0.045 | 0.344 | Growth hormone agonist | 0.344 0.024 DB13919 | DB13919 | |
| 0.308 | 0.129 | 0.308 | Antibacterial | 0.239 0.188 DBMET00006 0.218 0.209 DBMET00007 | ||
| 0.221 | 0.043 | 0.221 | Thrombolytic | |||
| 0.311 | 0.133 | 0.311 | Analgesic | |||
| 0.233 | 0.08 | 0.234 | Platelet antagonist | 0.182 0.115 DB13919 0.234 0.08 DBMET00006 0.156 0.138 DBMET00007 | DBMET00006 | |
| 0.116 | 0.004 | 0.116 | Nitric oxide donor | 0.058 0.051 DB13919 0.061 0.046 DBMET00007 | ||
| 0.107 | 0.004 | 0.333 | Angiotensin AT2 receptor antagonist | 0.112 0.003 DB13919 0.333 0.002 DBMET00005 0.065 0.007 DBMET00006 0.137 0.003 DBMET00007 | DBMET00005 | |
| 0.101 | 0.023 | 0.178 | Potassium channel large-conductance Ca-activated activator | 0.178 0.008 DB13919 0.094 0.027 DBMET00005 | DB13919 | |
| 0.084 | 0.008 | 0.084 | Factor XIa inhibitor | 0.04 0.03 DB13919 0.052 0.017 DBMET00005 | ||
| 0.146 | 0.07 | 0.146 | Cell wall synthesis inhibitor | |||
| 0.066 | 0.003 | 0.742 | Angiotensin AT1A receptor antagonist | 0.173 0.002 DB13919 0.742 0.001 DBMET00005 0.043 0.004 DBMET00006 0.249 0.002 DBMET00007 | DBMET00005 | |
| 0.175 | 0.114 | 0.175 | Hypolipemic | |||
| 0.065 | 0.011 | 0.241 | Glutamate (mGluR group II) agonist | 0.045 0.018 DB13919 0.241 0.004 DBMET00005 0.068 0.01 DBMET00007 | DBMET00005 | |
| 0.059 | 0.009 | 0.059 | Retinoic acid alpha receptor agonist | |||
| 0.07 | 0.021 | 0.07 | Lipocortins synthesis agonist | |||
| 0.09 | 0.042 | 0.312 | Phosphodiesterase 3A inhibitor | 0.193 0.009 DB13919 0.312 0.004 DBMET00005 0.121 0.022 DBMET00007 | DBMET00005 | |
| 0.058 | 0.011 | 0.234 | Glutamate (mGluR2) agonist | 0.04 0.018 DB13919 0.234 0.004 DBMET00005 0.063 0.01 DBMET00007 | DBMET00005 | |
| 0.068 | 0.038 | 0.178 | Glutamate (mGluR) agonist | 0.178 0.011 DBMET00005 | DBMET00005 | |
| 0.05 | 0.02 | 0.05 | Acetyl-CoA carboxylase inhibitor | |||
| 0.068 | 0.045 | 0.425 | Phosphodiesterase III inhibitor | 0.182 0.007 DB13919 0.425 0.004 DBMET00005 0.093 0.026 DBMET00007 | DBMET00005 | |
| 0.039 | 0.021 | 0.161 | Nicotinic acid receptor 2 agonist | 0.149 0.004 DB13919 0.161 0.004 DBMET00005 0.06 0.011 DBMET00007 | DBMET00005 | |
| 0.042 | 0.034 | 0.405 | Phosphodiesterase 3B inhibitor | 0.133 0.007 DB13919 0.405 0.003 DBMET00005 0.046 0.028 DBMET00007 | DBMET00005 | |
| 0.187 | 0.179 | 0.492 | Immunomodulator | 0.24 0.123 DB13919 0.383 0.049 DBMET00005 0.492 0.024 DBMET00006 0.412 0.04 DBMET00007 | DBMET00006 | |
| 0.083 | 0.076 | 0.146 | Uric acid excretion stimulant | 0.146 0.024 DB13919 0.105 0.049 DBMET00005 0.133 0.031 DBMET00006 0.083 0.078 DBMET00007 | DB13919 | |
| 0.036 | 0.03 | 0.121 | Glutamate (mGluR group II) antagonist | 0.121 0.004 DBMET00005 | DBMET00005 | |
| 0.013 | 0.01 | 0.315 | Angiotensin AT1B receptor antagonist | 0.072 0.002 DB13919 0.315 0.001 DBMET00005 0.02 0.006 DBMET00007 | DBMET00005 | |
| 0.028 | 0.025 | 0.028 | Squalene synthetase inhibitor | |||
| 0.084 | 0.083 | 0.186 | Xanthine oxidase inhibitor | 0.186 0.023 DB13919 0.153 0.033 DBMET00005 0.134 0.041 DBMET00007 | DB13919 | |
| 0.035 | 0.038 | 0.059 | Acid-sensing ion channel blocker | 0.059 0.01 DB13919 | DB13919 | |
| 0.023 | 0.036 | 0.061 | Growth hormone releasing factor agonist | 0.061 0.009 DB13919 | DB13919 | |
| 0.01 | 0.027 | 0.047 | Growth hormone release promoting | 0.047 0.006 DB13919 | DB13919 | |
| 0.021 | 0.046 | 0.096 | Glutamate (mGluR2) antagonist | 0.096 0.004 DBMET00005 | DBMET00005 | |
| 0.054 | 0.085 | 0.294 | Glutamate receptor agonist | 0.294 0.005 DBMET00005 | DBMET00005 | |
| 0.15 | 0.18 | 0.272 | Hypoglycemic | 0.258 0.072 DBMET00006 0.272 0.064 DBMET00007 | DBMET00007 | |
| 0.046 | 0.082 | 0.06 | Leukotriene synthesis inhibitor | 0.06 0.055 DB13919 | DB13919 | |
| 0.047 | 0.103 | 0.097 | Protein kinase B beta inhibitor | 0.072 0.054 DB13919 0.097 0.027 DBMET00005 | DBMET00005 | |
| 0.077 | 0.133 | 0.22 | Glutamate receptor antagonist | 0.22 0.021 DBMET00005 | DBMET00005 | |
| 0.085 | 0.15 | 0.567 | Interleukin 4 antagonist | 0.191 0.025 DB13919 0.567 0.004 DBMET00005 0.173 0.033 DBMET00006 0.177 0.031 DBMET00007 | DBMET00005 | |
| 0.01 | 0.078 | 0.174 | Leukotriene D4 antagonist | 0.027 0.017 DB13919 0.174 0.004 DBMET00005 0.054 0.009 DBMET00007 | DBMET00005 | |
| 0.063 | 0.131 | 0.154 | Interleukin 5 antagonist | 0.099 0.043 DB13919 0.154 0.01 DBMET00005 0.08 0.073 DBMET00006 | DBMET00005 | |
| 0.031 | 0.107 | 0.101 | Phosphodiesterase VII inhibitor | 0.087 0.02 DB13919 0.101 0.012 DBMET00005 | DBMET00005 | |
| 0.042 | 0.145 | 0.099 | Protein kinase B gamma inhibitor | 0.099 0.033 DBMET00005 | DBMET00005 | |
| 0.044 | 0.159 | 0.136 | Topoisomerase I inhibitor | 0.136 0.047 DBMET00006 0.094 0.075 DBMET00007 | DBMET00006 | |
| 0.055 | 0.172 | 0.416 | Phosphodiesterase 7B inhibitor | 0.113 0.043 DB13919 0.416 0.003 DBMET00005 0.289 0.004 DBMET00007 | DBMET00005 | |
| 0.033 | 0.153 | 0.079 | Prostaglandin F2 alpha antagonist | 0.079 0.024 DB13919 0.071 0.031 DBMET00005 | DB13919 | |
| 0.02 | 0.142 | 0.067 | Nicotinic acid receptor 1 agonist | 0.067 0.014 DB13919 | DB13919 | |
| 0.024 | 0.155 | 0.104 | Peroxisome proliferator-activated receptor gamma agonist | 0.095 0.031 DB13919 0.104 0.026 DBMET00005 0.074 0.045 DBMET00007 | DBMET00005 | |
| 0.076 | 0.208 | 0.187 | Diuretic | 0.187 0.049 DB13919 | DB13919 | |
| 0.02 | 0.163 | 0.061 | Maillard reaction inhibitor | 0.061 0.034 DB13919 | DB13919 | |
| 0.059 | 0.203 | 0.166 | Phosphodiesterase inhibitor | 0.166 0.048 DBMET00005 | DBMET00005 | |
| 0.102 | 0.253 | 0.142 | CC chemokine 6 receptor antagonist | 0.137 0.049 DB13919 0.142 0.036 DBMET00005 0.141 0.037 DBMET00006 0.141 0.038 DBMET00007 | DBMET00005 | |
| 0.035 | 0.193 | 0.076 | Interferon inducer | 0.076 0.028 DBMET00007 | DBMET00007 | |
| 0.006 | 0.171 | 0.059 | Purinergic P2Y12 antagonist | 0.059 0.005 DBMET00006 | DBMET00006 | |
| 0.092 | 0.271 | 0.306 | Antioxidant | 0.306 0.06 DBMET00007 | DBMET00007 | |
| 0.135 | 0.322 | 0.615 | Histamine release inhibitor | 0.615 0.009 DB13919 0.546 0.017 DBMET00005 0.366 0.092 DBMET00006 0.585 0.012 DBMET00007 | DB13919 | |
| 0.033 | 0.22 | 0.095 | Interferon agonist | 0.095 0.033 DBMET00007 | DBMET00007 | |
| 0.084 | 0.277 | 0.167 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.167 0.047 DB13919 0.162 0.053 DBMET00005 | DB13919 | |
| 0.052 | 0.246 | 0.09 | Toll-Like receptor 4 antagonist | 0.09 0.088 DBMET00007 | DBMET00007 | |
| 0.008 | 0.212 | 0.043 | CXC chemokine 3 receptor antagonist | 0.043 0.012 DBMET00005 | DBMET00005 | |
| 0.018 | 0.224 | 0.114 | Leukotriene antagonist | 0.098 0.023 DB13919 0.114 0.017 DBMET00005 0.065 0.044 DBMET00007 | DBMET00005 | |
| 0.021 | 0.227 | 0.064 | CXC chemokine receptor antagonist | 0.064 0.059 DBMET00005 | DBMET00005 | |
| 0.024 | 0.241 | 0.141 | NMDA receptor antagonist | 0.141 0.027 DBMET00005 | DBMET00005 | |
| 0.014 | 0.233 | 0.031 | Purinergic P2Y2 antagonist | 0.031 0.027 DBMET00006 | DBMET00006 | |
| 0.006 | 0.233 | 0.022 | Leukotriene B4 receptor 2 antagonist | 0.022 0.015 DBMET00005 | DBMET00005 | |
| 0.006 | 0.236 | 0.014 | Adenosine A2b receptor agonist | 0.014 0.01 DBMET00006 | DBMET00006 | |
| 0.092 | 0.352 | 0.293 | Immunosuppressant | 0.207 0.189 DBMET00006 0.293 0.12 DBMET00007 | DBMET00007 | |
| 0.008 | 0.269 | 0.127 | Nicotinic acid receptor agonist | 0.127 0.004 DB13919 0.073 0.008 DBMET00005 | DB13919 | |
| 0.024 | 0.291 | 0.172 | Potassium channel (Ca-activated) activator | 0.172 0.021 DB13919 0.148 0.028 DBMET00005 | DB13919 | |
| 0.023 | 0.311 | 0.324 | Alcohol dehydrogenase inhibitor | 0.276 0.006 DB13919 0.324 0.005 DBMET00005 0.137 0.025 DBMET00007 | DBMET00005 | |
| 0.014 | 0.325 | 0.082 | Myc inhibitor | 0.051 0.044 DB13919 0.082 0.012 DBMET00005 | DBMET00005 | |
| 0.052 | 0.365 | 0.209 | Platelet adhesion inhibitor | 0.146 0.111 DBMET00006 0.209 0.067 DBMET00007 | DBMET00007 | |
| 0.008 | 0.329 | 0.06 | Prostaglandin antagonist | 0.06 0.032 DBMET00005 | DBMET00005 | |
| 0.014 | 0.36 | 0.043 | Antibiotic Aminoglycoside-like | 0.043 0.018 DBMET00007 | DBMET00007 | |
| 0.013 | 0.36 | 0.049 | Protein 50S ribosomal subunit inhibitor | 0.049 0.041 DBMET00007 | DBMET00007 | |
| 0.122 | 0.472 | 0.619 | 5 Hydroxytryptamine release inhibitor | 0.619 0.009 DB13919 0.607 0.01 DBMET00005 0.509 0.03 DBMET00007 | DB13919 | |
| 0.018 | 0.369 | 0.052 | Autotaxin inhibitor | 0.052 0.037 DB13919 0.049 0.042 DBMET00005 | DB13919 | |
| 0.053 | 0.408 | 0.267 | Hepatoprotectant | 0.161 0.098 DBMET00006 0.267 0.039 DBMET00007 | DBMET00007 | |
| 0.008 | 0.371 | 0.123 | Phosphodiesterase 4D inhibitor | 0.123 0.027 DBMET00005 | DBMET00005 | |
| 0.02 | 0.389 | 0.12 | Bombesin 3 receptor antagonist | 0.12 0.007 DBMET00005 0.054 0.04 DBMET00007 | DBMET00005 | |
| 0.018 | 0.401 | 0.048 | Glucagon-like peptide 1 receptor antagonist | 0.048 0.015 DBMET00005 | DBMET00005 | |
| 0.01 | 0.423 | 0.096 | Protein-tyrosine phosphatase 1B inhibitor | 0.096 0.082 DBMET00007 | DBMET00007 | |
| 0.007 | 0.432 | 0.091 | Phosphodiesterase 4C inhibitor | 0.091 0.017 DBMET00005 | DBMET00005 | |
| 0.061 | 0.492 | 0.257 | Gastrin inhibitor | 0.257 0.071 DB13919 | DB13919 | |
| 0.015 | 0.447 | 0.054 | Heparanase inhibitor | 0.054 0.034 DBMET00006 | DBMET00006 | |
| 0.004 | 0.439 | 0.025 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.025 0.024 DBMET00005 | DBMET00005 | |
| 0.005 | 0.453 | 0.066 | Prostaglandin E2 antagonist | 0.066 0.025 DBMET00005 | DBMET00005 | |
| 0.048 | 0.524 | 0.195 | Antithrombotic | 0.195 0.184 DBMET00007 | DBMET00007 | |
| 0.031 | 0.549 | 0.097 | Transcription factor NF kappa B stimulant | 0.097 0.041 DBMET00007 | DBMET00007 | |
| 0.001 | 0.539 | 0.108 | Kainate receptor 1 antagonist | 0.108 0.004 DBMET00005 | DBMET00005 | |
| 0.009 | 0.553 | 0.057 | Cytokine production stimulant | 0.055 0.018 DBMET00006 0.057 0.017 DBMET00007 | DBMET00007 | |
| 0.006 | 0.55 | 0.159 | Selectin antagonist | 0.159 0.017 DBMET00007 | DBMET00007 | |
| 0.003 | 0.549 | 0.029 | Nicotinic acid receptor 2 antagonist | 0.029 0.014 DB13919 0.026 0.02 DBMET00005 | DB13919 | |
| 0.024 | 0.579 | 0.118 | DNA polymerase I inhibitor | 0.118 0.07 DBMET00006 | DBMET00006 | |
| 0.005 | 0.567 | 0.056 | Phosphodiesterase 2A inhibitor | 0.056 0.027 DBMET00005 | DBMET00005 | |
| 0.016 | 0.585 | 0.325 | Immunostimulant | 0.298 0.079 DBMET00006 0.325 0.072 DBMET00007 | DBMET00007 | |
| 0.004 | 0.578 | 0.064 | Phosphodiesterase II inhibitor | 0.064 0.028 DBMET00005 | DBMET00005 | |
| 0.025 | 0.599 | 0.201 | Nitric oxide antagonist | 0.201 0.067 DBMET00007 | DBMET00007 | |
| 0.025 | 0.601 | 0.113 | NADPH oxidase inhibitor | 0.113 0.092 DB13919 | DB13919 | |
| 0.003 | 0.596 | 0.06 | Kainate receptor 5 antagonist | 0.06 0.005 DBMET00005 | DBMET00005 | |
| 0.012 | 0.606 | 0.125 | Aminoacyl-tRNA synthetase inhibitor | 0.125 0.028 DBMET00006 | DBMET00006 | |
| 0.005 | 0.606 | 0.059 | Purinergic P2 antagonist | 0.059 0.049 DBMET00006 | DBMET00006 | |
| 0.007 | 0.614 | 0.063 | Leukotriene C antagonist | 0.063 0.024 DBMET00005 | DBMET00005 | |
| 0.004 | 0.614 | 0.186 | Protein kinase (CK2) inhibitor | 0.138 0.039 DB13919 0.186 0.022 DBMET00005 | DBMET00005 | |
| 0.003 | 0.619 | 0.09 | Purinergic P2Y antagonist | 0.09 0.011 DBMET00006 | DBMET00006 | |
| 0.019 | 0.635 | 0.053 | Adenine nucleotide translocase inhibitor | 0.053 0.047 DBMET00006 | DBMET00006 | |
| 0.011 | 0.629 | 0.089 | Adenosine A3 receptor antagonist | 0.089 0.033 DBMET00006 | DBMET00006 | |
| 0.004 | 0.635 | 0.04 | Leukotriene C4 antagonist | 0.04 0.023 DBMET00005 | DBMET00005 | |
| 0.03 | 0.661 | 0.266 | Cholesterol antagonist | 0.266 0.114 DBMET00007 | DBMET00007 | |
| 0.001 | 0.67 | 0.018 | Nicotinic acid receptor 1 antagonist | 0.018 0.011 DBMET00005 | DBMET00005 | |
| 0.002 | 0.672 | 0.123 | Kainate receptor antagonist | 0.123 0.005 DBMET00005 | DBMET00005 | |
| 0.02 | 0.692 | 0.28 | Cyclic AMP phosphodiesterase inhibitor | 0.28 0.05 DBMET00006 | DBMET00006 | |
| 0.022 | 0.701 | 0.07 | Heme oxygenase stimulant | 0.07 0.025 DBMET00005 | DBMET00005 | |
| 0.066 | 0.746 | 0.264 | Peptidyltransferase inhibitor | 0.264 0.042 DBMET00006 0.256 0.046 DBMET00007 | DBMET00006 | |
| 0.012 | 0.692 | 0.077 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.077 0.069 DBMET00005 | DBMET00005 | |
| 0.014 | 0.695 | 0.381 | Angiogenesis stimulant | 0.163 0.114 DBMET00006 0.381 0.025 DBMET00007 | DBMET00007 | |
| 0.059 | 0.748 | 0.319 | Interleukin 2 agonist | 0.319 0.061 DBMET00007 | DBMET00007 | |
| 0.003 | 0.692 | 0.026 | Adenosine A1 receptor agonist | 0.026 0.015 DBMET00006 | DBMET00006 | |
| 0.004 | 0.715 | 0.107 | Phosphodiesterase 4B inhibitor | 0.107 0.022 DBMET00005 | DBMET00005 | |
| 0.002 | 0.72 | 0.031 | Prostaglandin EP4 antagonist | 0.031 0.014 DBMET00005 | DBMET00005 | |
| 0.003 | 0.727 | 0.026 | Kainate receptor 3 antagonist | 0.026 0.006 DBMET00005 | DBMET00005 | |
| 0.009 | 0.743 | 0.275 | Free radical scavenger | 0.275 0.059 DBMET00007 | DBMET00007 | |
| 0.004 | 0.744 | 0.016 | Adenosine A3 receptor agonist | 0.016 0.015 DBMET00006 | DBMET00006 | |
| 0.003 | 0.746 | 0.058 | Kainate receptor 4 antagonist | 0.058 0.005 DBMET00005 | DBMET00005 | |
| 0.024 | 0.772 | 0.135 | DNA repair enzyme inhibitor | 0.135 0.048 DBMET00006 | DBMET00006 | |
| 0.012 | 0.772 | 0.148 | Insulin secretagoues | 0.148 0.076 DBMET00006 0.123 0.107 DBMET00007 | DBMET00006 | |
| 0.002 | 0.781 | 0.186 | Protein kinase (CK2) alpha inhibitor | 0.096 0.08 DB13919 0.186 0.028 DBMET00005 | DBMET00005 | |
| 0.003 | 0.791 | 0.114 | AMPA 2 receptor antagonist | 0.114 0.005 DBMET00005 | DBMET00005 | |
| 0.002 | 0.795 | 0.14 | AMPA receptor antagonist | 0.042 0.041 DB13919 0.14 0.006 DBMET00005 | DBMET00005 | |
| 0.006 | 0.814 | 0.167 | AMP-activated protein kinase stimulant | 0.099 0.072 DBMET00006 0.167 0.019 DBMET00007 | DBMET00007 | |
| 0.004 | 0.829 | 0.044 | Glutamate (mGluR group III) antagonist | 0.044 0.03 DBMET00005 | DBMET00005 | |
| 0.005 | 0.834 | 0.075 | Phosphodiesterase 1C inhibitor | 0.075 0.024 DBMET00005 | DBMET00005 | |
| 0.014 | 0.854 | 0.105 | Amylase inhibitor | 0.105 0.092 DBMET00007 | DBMET00007 | |
| 0.008 | 0.859 | 0.051 | Carnitine palmitoyltransferase 1B inhibitor | 0.051 0.027 DBMET00005 | DBMET00005 | |
| 0.008 | 0.859 | 0.24 | DNA methyltransferase I inhibitor | 0.24 0.051 DBMET00006 | DBMET00006 | |
| 0.004 | 0.859 | 0.038 | Carbonic anhydrase I stimulant | 0.038 0.026 DBMET00005 | DBMET00005 | |
| 0.021 | 0.885 | 0.21 | Apoptosis antagonist | 0.21 0.167 DBMET00007 | DBMET00007 | |
| 0.004 | 0.871 | 0.223 | Alpha-glucosidase inhibitor | 0.223 0.204 DBMET00007 | DBMET00007 | |
| 0.011 | 0.882 | 0.054 | Carbonic anhydrase II stimulant | 0.054 0.031 DBMET00005 | DBMET00005 | |
| 0.008 | 0.889 | 0.246 | DNA methylase inhibitor | 0.246 0.05 DBMET00006 | DBMET00006 | |
| 0.007 | 0.894 | 0.195 | Hypoxia-inducible factor 1 alpha inhibitor | 0.195 0.158 DBMET00006 | DBMET00006 | |
| 0.001 | 0.897 | 0.247 | NMDA receptor subunit 3A antagonist | 0.247 0.004 DBMET00005 | DBMET00005 | |
| 0.002 | 0.899 | 0.05 | Sphingosine kinase 2 inhibitor | 0.05 0.047 DBMET00005 | DBMET00005 | |
| 0.003 | 0.904 | 0.295 | I kappa B kinase epsilon inhibitor | 0.295 0.017 DBMET00005 | DBMET00005 | |
| 0.007 | 0.908 | 0.086 | Bile acid receptor antagonist | 0.086 0.085 DBMET00005 | DBMET00005 | |
| 0.001 | 0.91 | 0.214 | NMDA receptor subunit 3B antagonist | 0.214 0.004 DBMET00005 | DBMET00005 | |
| 0.004 | 0.925 | 0.05 | Glutamate (mGluR4) antagonist | 0.05 0.021 DBMET00005 | DBMET00005 | |
| 0 | 0.925 | 0.028 | AMPA 1 receptor antagonist | 0.028 0.021 DBMET00005 | DBMET00005 | |
| 0.001 | 0.932 | 0.1 | AMPA 4 receptor antagonist | 0.1 0.005 DBMET00005 | DBMET00005 | |
| 0.001 | 0.932 | 0.071 | Kainate receptor 2 antagonist | 0.071 0.008 DBMET00005 | DBMET00005 | |
| 0.004 | 0.939 | 0.239 | DNA synthesis inhibitor | 0.239 0.074 DBMET00006 | DBMET00006 | |
| 0.001 | 0.953 | 0.048 | AMPA 3 receptor antagonist | 0.048 0.009 DBMET00005 | DBMET00005 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |